Since leukocytes are known to promote metastasis via cross-talk signaling with cancer cells (7, 24), the observation of reduced macrophage and neutrophil counts in mammary tumors following Rac inhibition validates a dual role for Rac/Cdc42 inhibitors in tumor malignancy. This evidence concerns the gene CDC42 and cancer.